Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionVident Advisory, LLC
Latest Disclosed Ownership264,293 shares
Latest Disclosed Value $ 16,029,380
Vident Advisory, LLC reports 161.10% increase in ownership of BRM / Bristol-Myers Squibb Company

On May 14, 2026 - Vident Advisory, LLC filed a 13F-HR form disclosing ownership of 264,293 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $13,854,239 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 101,221 shares of Bristol-Myers Squibb Company. This represents a change in shares of 161.10% during the quarter. The current value of the position is $12,535,417 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 264,293 163,072 161.10 16,029 193.63 0.0434
2026-02-18 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 101,221 -889 -0.87 5,460 18.55 0.0497
2025-11-14 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 102,110 -22,217 -17.87 4,605 -19.98 0.0440
2025-08-14 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 124,327 -22,865 -15.53 5,755 -35.89 0.0646
2025-05-15 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 147,192 72,679 97.54 8,977 113.03 0.1312
2025-02-14 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 74,513 -3,382 -4.34 4,215 4.57 0.0739
2024-11-14 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 77,895 -91,569 -54.03 4,031 -42.73 0.1014
2024-08-14 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 169,464 -605,522 -78.13 7,038 -83.26 0.1944
2024-05-14 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 774,986 224,992 40.91 42,028 48.93 0.8755
2024-02-14 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 549,994 55,897 11.31 28,220 -1.59 0.7093
2024-02-21 2023-09-30 13F/A-01 BRISTOL-MYERS SQUIBB COM 110122108 494,097 494,097 28,677 0.8885
2023-11-14 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 494,097 494,097 28,677 0.7154
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.